All stock lists
Ferrari N.V. (New York Stock Exchange:RACE)
IT · Delayed Price · Currency is USD
Also listed: 2FE.DE, RACE.MI, RACE.SWConsumer Cyclical · Auto - Manufacturers
418.96+15.87 (+3.94%)
Market cap
$73.4B
Insider Score
Health Score
Analyst consensus
Listed since
Oct 21, 2015
Website
Insider Score
––Not scored
RACE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Strong
From RACE’s reported statements · Q3 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $7.48B
- Net income
- $1.68B
- Net margin
- 22.5%
Leverage18 / 20
Little or no net debt.
- Total debt
- $3.12B
- Cash
- $1.73B
- Net debt / EBITDA
- 0.47x
Liquidity13 / 20
Covers near-term obligations, without much room.
- Current assets
- $5.41B
- Current liabilities
- $3.75B
- Current ratio
- 1.44
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $4.39B
- Free cash flow
- $2.98B
- FCF margin
- 39.8%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 175.7M
- Share growth (1y)
- -1.4%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
RACE Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | 1.90 B | 1.93 B | 1.85 B | 1.80 B | 1.77 B | 1.79 B |
| Revenue Growth (YoY) | 7.36 % | 8.24 % | 3.20 % | 3.79 % | 7.40 % | 4.41 % |
| Cost of Revenue | 902.42 M | 917.27 M | 890.14 M | 866.71 M | 882.18 M | 846.59 M |
| Gross Profit | 993.79 M | 1.02 B | 957.93 M | 934.60 M | 883.98 M | 940.96 M |
| SG&A Expense | 173.75 M | 187.79 M | 160.58 M | 173.12 M | 160.33 M | 159.97 M |
| R&D Expense | 251.52 M | 217.18 M | 245.18 M | 238.91 M | 222.17 M | 224.99 M |
| Operating Expenses | 430.58 M | 404.97 M | 405.76 M | 425.94 M | 382.50 M | 384.96 M |
| Operating Income | 563.21 M | 612.63 M | 552.17 M | 508.66 M | 501.47 M | 556.00 M |
| Pretax Income | 559.05 M | 600.12 M | 536.83 M | 500.99 M | 489.38 M | 545.00 M |
| Tax Provision | 128.58 M | 138.03 M | 123.47 M | 120.34 M | 107.66 M | 119.90 M |
| Net Income | 429.91 M | 461.55 M | 412.86 M | 379.69 M | 381.32 M | 424.27 M |
| EPS (Basic) | 2.45 | 2.62 | 2.35 | 2.14 | 2.14 | 2.38 |
| EPS (Diluted) | 2.44 | 2.61 | 2.34 | 2.14 | 2.14 | 2.38 |
| Shares Outstanding | 175.73 M | 176.23 M | 176.98 M | 178.32 M | 178.19 M | 178.22 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.